On Aug 26, 2021 Neurogastrx closed a Series B round and raised $60,000,000 from 5AM Ventures, Marshall Wace, OrbiMed, RTW Investments LLC, Samsara BioCapital, venBio Partners, Vivo Capital, featuring lead investors Vivo Capital.
About the company: Neurogastrx is located at United States, North America.
“”
Company website: http://www.neurogastrx.com